Return On Equity of Dare Bioscience, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Dare Bioscience, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Dare Bioscience, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 274%, a 183% increase year-over-year.
  • Dare Bioscience, Inc. annual Return On Equity for 2024 was 102%, a 96% decline from 2023.
  • Dare Bioscience, Inc. annual Return On Equity for 2023 was 2373%.
  • Dare Bioscience, Inc. annual Return On Equity for 2022 was -122%, a 36% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Dare Bioscience, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 274% +177% +183% 01 Jul 2025 30 Sep 2025
Q2 2025 250% +66% +36% 01 Apr 2025 30 Jun 2025
Q1 2025 47% -502% -92% 01 Jan 2025 31 Mar 2025
Q4 2024 102% -2270% -96% 01 Oct 2024 31 Dec 2024
Q3 2024 97% +1579% 01 Jul 2024 30 Sep 2024
Q2 2024 184% +584% 01 Apr 2024 30 Jun 2024
Q1 2024 549% +711% 01 Jan 2024 31 Mar 2024
Q4 2023 2373% +2495% 01 Oct 2023 31 Dec 2023
Q3 2023 -1482% -1406% -1848% 01 Jul 2023 30 Sep 2023
Q2 2023 -401% -311% -346% 01 Apr 2023 30 Jun 2023
Q1 2023 -162% -17% -11% 01 Jan 2023 31 Mar 2023
Q4 2022 -122% +67% +36% 01 Oct 2022 31 Dec 2022
Q3 2022 -76% +284% +79% 01 Jul 2022 30 Sep 2022
Q2 2022 -90% +1447% +94% 01 Apr 2022 30 Jun 2022
Q1 2022 -146% +11667% +99% 01 Jan 2022 31 Mar 2022
Q4 2021 -190% +10906% +98% 01 Oct 2021 31 Dec 2021
Q3 2021 -360% +3178% +90% 01 Jul 2021 30 Sep 2021
Q2 2021 -1536% -246% -19% 01 Apr 2021 30 Jun 2021
Q1 2021 -11812% -11226% -1914% 01 Jan 2021 31 Mar 2021
Q4 2020 -11095% -10582% -2061% 01 Oct 2020 31 Dec 2020
Q3 2020 -3538% -3232% -1056% 01 Jul 2020 30 Sep 2020
Q2 2020 -1291% -1092% -550% 01 Apr 2020 30 Jun 2020
Q1 2020 -586% -436% -291% 01 Jan 2020 31 Mar 2020
Q4 2019 -513% -362% -240% 01 Oct 2019 31 Dec 2019
Q3 2019 -306% -126% -70% 01 Jul 2019 30 Sep 2019
Q2 2019 -199% -60% -44% 01 Apr 2019 30 Jun 2019
Q1 2019 -150% +1% +0.68% 01 Jan 2019 31 Mar 2019
Q4 2018 -151% -41% -38% 01 Oct 2018 31 Dec 2018
Q3 2018 -180% -76% -73% 01 Jul 2018 30 Sep 2018
Q2 2018 -138% -35% -34% 01 Apr 2018 30 Jun 2018
Q1 2018 -151% -21% -16% 01 Jan 2018 31 Mar 2018
Q4 2017 -110% +42% +28% 01 Oct 2017 31 Dec 2017
Q3 2017 -105% +75% +42% 01 Jul 2017 30 Sep 2017
Q2 2017 -103% +49% +32% 01 Apr 2017 30 Jun 2017
Q1 2017 -130% -20% -18% 01 Jan 2017 31 Mar 2017
Q4 2016 -151% -56% -60% 01 Oct 2016 31 Dec 2016
Q3 2016 -179% -111% -162% 01 Jul 2016 30 Sep 2016
Q2 2016 -152% -91% -150% 01 Apr 2016 30 Jun 2016
Q1 2016 -110% -51% -87% 01 Jan 2016 31 Mar 2016
Q4 2015 -95% +65% +41% 01 Oct 2015 31 Dec 2015
Q3 2015 -68% -164% -172% 01 Jul 2015 30 Sep 2015
Q2 2015 -61% 01 Apr 2015 30 Jun 2015
Q1 2015 -59% 01 Jan 2015 31 Mar 2015
Q4 2014 -159% 01 Oct 2014 31 Dec 2014
Q3 2014 96% 01 Jul 2014 30 Sep 2014

Dare Bioscience, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 102% -2270% -96% 01 Jan 2024 31 Dec 2024
2023 2373% +2495% 01 Jan 2023 31 Dec 2023
2022 -122% +67% +36% 01 Jan 2022 31 Dec 2022
2021 -190% +10906% +98% 01 Jan 2021 31 Dec 2021
2020 -11095% -10582% -2061% 01 Jan 2020 31 Dec 2020
2019 -513% -362% -240% 01 Jan 2019 31 Dec 2019
2018 -151% -41% -38% 01 Jan 2018 31 Dec 2018
2017 -110% -106% -3064% 01 Jan 2017 31 Dec 2017
2016 -3.5% +91% +96% 01 Jan 2016 31 Dec 2016
2015 -95% +65% +41% 01 Jan 2015 31 Dec 2015
2014 -159% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.